Peer Review reports
From: l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study
| Original Submission | ||
|---|---|---|
| 31 Jan 2022 | Submitted | Original manuscript |
| 3 Feb 2022 | Reviewed | Reviewer Report |
| 20 Feb 2022 | Reviewed | Reviewer Report |
| 12 Apr 2022 | Author responded | Author comments - Jie Zhao |
| Resubmission - Version 2 | ||
| 12 Apr 2022 | Submitted | Manuscript version 2 |
| 13 Apr 2022 | Reviewed | Reviewer Report |
| 27 Apr 2022 | Reviewed | Reviewer Report |
| 6 Jun 2022 | Author responded | Author comments - Jie Zhao |
| Resubmission - Version 3 | ||
| 6 Jun 2022 | Submitted | Manuscript version 3 |
| 19 Jun 2022 | Reviewed | Reviewer Report |
| 5 Jul 2022 | Author responded | Author comments - Jie Zhao |
| Resubmission - Version 4 | ||
| 5 Jul 2022 | Submitted | Manuscript version 4 |
| Publishing | ||
| 12 Jul 2022 | Editorially accepted | |
| 1 Sep 2022 | Article published | 10.1186/s12916-022-02477-z |
You can find further information about peer review here.